PLD4
5'-3' exonuclease PLD4
Also known as: C14orf175, PLD4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96BZ4
- Gene
- PLD4
- Ensembl
- ENSG00000166428
- Chromosome
- 14
- Canonical length
- 506 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to enable single-stranded DNA 5'-3' DNA exonuclease activity. Predicted to be involved in hematopoietic progenitor cell differentiation; phagocytosis; and regulation of cytokine production involved in inflammatory response. Predicted to act upstream of or within establishment of localization in cell. Predicted to be located in early endosome and endoplasmic reticulum membrane. Predicted to be active in several cellular components, including endoplasmic reticulum; phagocytic vesicle; and trans-Golgi network membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
506 residues, UniProt reviewed canonical sequence.
>Q96BZ4|PLD4
1 MLKPLWKAAV APTWPCSMPP RRPWDREAGT LQVLGALAVL WLGSVALICL LWQVPRPPTW
61 GQVQPKDVPR SWEHGSSPAW EPLEAEARQQ RDSCQLVLVE SIPQDLPSAA GSPSAQPLGQ
121 AWLQLLDTAQ ESVHVASYYW SLTGPDIGVN DSSSQLGEAL LQKLQQLLGR NISLAVATSS
181 PTLARTSTDL QVLAARGAHV RQVPMGRLTR GVLHSKFWVV DGRHIYMGSA NMDWRSLTQV
241 KELGAVIYNC SHLAQDLEKT FQTYWVLGVP KAVLPKTWPQ NFSSHFNRFQ PFHGLFDGVP
301 TTAYFSASPP ALCPQGRTRD LEALLAVMGS AQEFIYASVM EYFPTTRFSH PPRYWPVLDN
361 ALRAAAFGKG VRVRLLVGCG LNTDPTMFPY LRSLQALSNP AANVSVDVKV FIVPVGNHSN
421 IPFSRVNHSK FMVTEKAAYI GTSNWSEDYF SSTAGVGLVV TQSPGAQPAG ATVQEQLRQL
481 FERDWSSRYA VGLDGQAPGQ DCVWQGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLD4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 18 nTPM
- midbrain: 16 nTPM
- bone marrow: 13 nTPM
- lymph node: 11 nTPM
- spleen: 9.8 nTPM
- amygdala: 9.3 nTPM
Single-cell type
- pdcs: 616 nCPM
- microglia: 136 nCPM
- cdc: 42 nCPM
- macrophages: 39 nCPM
- hofbauer cells: 34 nCPM
- epicardial cells: 25 nCPM
Immune cell
- plasmacytoid DC: 3,629 nTPM
- eosinophil: 701 nTPM
- myeloid DC: 547 nTPM
- non-classical monocyte: 299 nTPM
- memory B-cell: 224 nTPM
- naive B-cell: 199 nTPM
Brain region
- white matter: 42 nTPM
- medulla oblongata: 39 nTPM
- spinal cord: 36 nTPM
- pons: 28 nTPM
- thalamus: 26 nTPM
- hypothalamus: 22 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.17
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- establishment of localization in cell
- hematopoietic progenitor cell differentiation
- inflammatory response
- innate immune response
- lipid metabolic process
- phagocytosis
- regulation of cytokine production involved in inflammatory response
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLD4 as an antibody target. Whether an autoantibody or antibody against PLD4 could matter depends on whether native PLD4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLD4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PLD4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...